Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

10.2K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
10.2K
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

3.9K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
3.9K
Mitochondrial Protein Sorting01:39

Mitochondrial Protein Sorting

6.0K
Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death.  Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
6.0K
Mitochondrial Membranes01:45

Mitochondrial Membranes

18.0K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
18.0K
Mitochondrial Membranes01:45

Mitochondrial Membranes

2.4K
2.4K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

869
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
869

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond motor neurons: peripheral TDP-43 pathology in skeletal muscle and intramuscular nerves in amyotrophic lateral sclerosis.

Brain communications·2026
Same author

Glycogenin-1 deficiency: a case report and review of the literature.

Frontiers in genetics·2026
Same author

Population-level impact of quadrivalent HPV vaccination in Brazil: a repeated cross-sectional study.

NPJ vaccines·2026
Same author

Ataxia With Vitamin E Deficiency Syndrome and a Novel <i>TTPA</i> Variant: A Paired Case Report.

Neurology. Genetics·2026
Same author

Combined omalizumab and desensitization to control IgE-mediated hypersensitivity in enzyme replacement therapy for late-onset Pompe disease.

Orphanet journal of rare diseases·2026
Same author

High-plex spatial protein profiling of skeletal muscle biopsies in inflammatory myopathies using the MACSima™ imaging platform: A pilot study.

Acta neuropathologica communications·2026

Related Experiment Video

Updated: Apr 17, 2026

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
06:05

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model

Published on: March 9, 2022

4.6K

Mitochondrial disease heterogeneity: a prognostic challenge.

Maurizio Moggio1, Irene Colombo1, Lorenzo Peverelli1

  • 1UOD Malattie Neuromuscolari e Rare, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Centro Dino Ferrari, Università degli Studi di Milano, Milan, Italy;

Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology
|February 25, 2015
PubMed
Summary

Mitochondrial diseases, caused by impaired mitochondrial function, have unpredictable progression due to genetic factors and organ involvement. Early symptom recognition and treatment are crucial for managing mitochondrial myopathies and preventing severe complications.

Keywords:
clinical heterogeneitydual genetic controlintrafamilial variabilitymultisystem disorders

More Related Videos

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
08:56

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

Published on: October 10, 2025

915
Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

2.1K

Related Experiment Videos

Last Updated: Apr 17, 2026

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
06:05

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model

Published on: March 9, 2022

4.6K
Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
08:56

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

Published on: October 10, 2025

915
Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

2.1K

Area of Science:

  • Genetics
  • Molecular Biology
  • Neurology

Background:

  • Mitochondrial diseases are complex, inherited disorders affecting multiple organ systems due to mitochondrial dysfunction.
  • The clinical course of mitochondrial myopathies is highly variable, making prognosis challenging.
  • Mitochondrial DNA (mtDNA) point mutations, inherited maternally, contribute to this variability through heteroplasmy.

Purpose of the Study:

  • To highlight the unpredictable nature of mitochondrial disease progression.
  • To emphasize the importance of individualized prognosis based on disease-specific events and complications.
  • To underscore the critical role of early diagnosis and intervention in managing mitochondrial disorders.

Main Methods:

  • Review of existing literature on mitochondrial diseases and myopathies.
  • Analysis of factors influencing disease variability and prognosis.
  • Discussion of diagnostic and therapeutic strategies.

Main Results:

  • Disease progression in mitochondrial myopathies is patient-specific, influenced by mutation type and organ involvement.
  • Prognosis is unpredictable, even within families or for individuals with the same mutation.
  • Heteroplasmy in mtDNA point mutations adds to the variability and unpredictability.

Conclusions:

  • Prognosis for mitochondrial diseases should be event-specific rather than disease-specific.
  • Early identification and management of symptoms and complications are vital for improving patient outcomes.
  • A proactive approach to diagnosis and treatment can mitigate severe organ dysfunction.